| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |